The Lund Report

Audit: Oregon’s Program That Monitors Controlled Drugs Is Ineffective, Underused

An analysis by the Secretary of State’s Office found that a program that collects prescription information has loopholes that prevent it being used to stem the opioid epidemic.

The Oregon Health Authority adopted a prescription monitoring program in 2011 to help prevent the abuse of controlled substances like opioids and help ensure that prescription medicines are used safely. 

Experts Begin Review Of OHSU's Collapsed Heart Transplant Program And Cardiology Institute

Three months after the heart transplant unit imploded, four outside specialists are launching what's called a "peer review," a confidential process that will look at what when went wrong in the unit and the Knight Cardiovascular Institute and make recommendations on how to move forward.

When its heart transplant program imploded in August, Oregon Health & Science University promised a peer review to get to the root of the problems that led to the departure of its four heart failure cardiologists and the need to transfer hun

OHSU's Chief Names Head Of Research In First Executive Appointment.

Peter Barr-Gillespie will earn $500,000 in his new role overseeing research at Oregon Health & Science University and advising President Dr. Danny Jacobs.

Oregon Health & Science University’s new president has appointed one of the university’s top scientists his chief advisor on research strategy and a member of the executive team.

Oregon Aims to Eliminate Hepatitis C Infections

The state has the highest mortality rate in the country but a move by the Oregon Health Authority to expand expensive treatment could wipe out the virus, if medical modeling is correct.

The Oregon Health Authority is moving to expand treatment for hepatitis C to everyone on the Oregon Health Plan who’s infected.

Pages

Subscribe to The Lund Report